Telix Pharmaceuticals (TLX) Equity Average (2024)
Telix Pharmaceuticals has reported Equity Average over the past 1 years, most recently at $234.3 million for Q4 2024.
- Quarterly Equity Average changed N/A to $234.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $234.3 million through Dec 2024, changed N/A year-over-year, with the annual reading at $234.3 million for FY2024, 207.13% up from the prior year.
- Equity Average was $234.3 million for Q4 2024 at Telix Pharmaceuticals.
- Over five years, Equity Average peaked at $234.3 million in Q4 2024 and troughed at $234.3 million in Q4 2024.